Article
Genetic variants in glutamine metabolic pathway genes predict cutaneous melanoma-specific survival.
Molecular carcinogenesis - 1 Nov 2019
Chen Ka, Liu Hongliang, Liu Zhensheng, Bloomer Wendy, Amos Christopher I, Lee Jeffrey E, Li Xin, Nan Hongmei, Wei Qingyi
Abstract excerpt
Glutamine dependence is a unique metabolic defect seen in cutaneous melanoma (CM), directly influencing the treatment and prognosis. Here, we investigated the associations between 6025 common single-nucleotide polymorphisms (SNPs) in 77 glutamine metabolic pathway genes with CM-specific survival (CMSS) using genotyping datasets from two published genome-wide association studies (GWASs). In the single-locus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
